NEW YORK (AP) -- Andrew Witty, who took over as GlaxoSmithKline PLC's chief executive in May 2008, has been remaking the company from a pure pharmaceutical business to a diverse healthcare conglomerate, a strategy most rivals now are pursuing....
Glaxo CEO: Time to diversify, help poor countriesCourtesy Headlines from the Associated Press Tue, 02/02/2010 - 15:56
NEW YORK (AP) -- Andrew Witty, who took over as GlaxoSmithKline PLC's chief executive in May 2008, has been remaking the company from a pure pharmaceutical business to a diverse healthcare conglomerate, a strategy most rivals now are pursuing.... More related itemsBatch of swine flu vaccines studied in Canada
GlaxoSmithKline pulls swine flu vaccines in Canada
FDA questions safety of Glaxo kidney cancer drug
Alcohawk Precision Digital Alcohol Breath Tester
Genuine Magnetrainer ER (Extended Range) Mini...
|
Popular by tags WeekMonth |
Post new comment